Chemical penetration enhancer
1.

Introduction
The self-assembly of non-ionic surfactants into vesicles represents an interesting opportunity to achieve vesicular colloidal drug carriers, so-called niosomes, which resemble liposomes in their architecture and can be used as an effective alternative to liposomal drug carriers [1] . Niosomes have been proposed for a number of potential therapeutic applications. In particular, they have been intensively used as effective dermal and transdermal drug delivery systems [2e5] . Ellagic acid (EA) is a potent antioxidant phytochemical substance which has skin-whitening property with photoprotective effect [6] [7] . However, it is poorly soluble in water (w9.7 mg/ml) [8] and not soluble in many organic solvents, leading to difficulties in the design of pharmaceutical formulations. In our previous study [9] , we demonstrated that the 2:1 Span 60 and Tween 60 niosomes were able to encapsulate and deliver EA through human epidermis and dermis.
One generalized approach to overcome the barrier properties of the skin for drugs and biomolecules is an incorporation of suitable vehicles or other chemical compounds into transdermal delivery systems. Substances that promote the penetration of topically applied drugs through stratum corneum and epidermis are commonly referred to as skin permeation enhancers, accelerants, adjuvants, or sorption promoters [10] . Chemical skin permeation enhancers have been generally used to promote the drug permeation through the skin [11, 12] . Dimethylsulfoxide (DMSO) is one of the earliest and most widely studied penetration enhancers and often used in many areas of pharmaceutical sciences as a "universal solvent". It has been postulated that DMSO denatures the intercellular structural protein of the stratum corneum [13] , or promote lipid fluidity by disruption of the ordered structure of the lipid chains [14] . Although DMSO at high concentration of >60% was reported to induce erythema and wheals of the stratum corneum, it has been used as nonirritant skin penetration enhancer at 10% in many skin formulations [15] . N-methyl-2-pyrrolidone (NMP) is a polar aprotic solvent and miscible with most common solvents including water and alcohols. NMP can partition well into human stratum corneum. Within the tissue, it may act by altering the solvent nature of membrane and has been used to generate "reservoirs" within skin membranes [16] . It was also used as skin penetration enhancer in many topical formulations at the concentration up to 40% without any skin sensitization [17e19]. However, it has been reported that NMP metabolite, 5-hydroxy-N-methyl pyrrolidone was observed in urine after skin exposure with 5% solution of NMP [20] . To our knowledge, there are no reports on use of NMP as a penetration enhancer in formulation of liposomes and niosomes. Hence, it is of our interest to investigate the potential of DMSO and NMP to enhance skin permeation of EA when added into niosomal formulations. In this study, the EA-loaded niosomes were prepared by using mixture of two non-ionic surfactants, 2:1 Span 60 and Tween 60, and cholesterol as the main components of the vesicular bilayer. In addition, Solulan C24 and two chemical penetration enhancers (10% v/v DMSO and 1% v/ v NMP) were used as membrane additives. The vesicular systems were characterized in order to evaluate the capability of the permeation enhancers to destabilize the lipid bilayers and to improve dermal delivery of EA.
2.
Materials and methods
Materials
Sorbitan monostearate (Span 60) and polyethylene glycol sorbitan monostearate (Tween 60) were obtained from Uniqema (Chicago, USA). Ellagic acid (EA) and polyethylene glycol 400 (PEG) were purchased from Fluka (West St. Paul, USA). Cholesteryl poly-24-oxyethylene ether (Solulan C24) was received as a gift sample from Amerchol (New Jersey, USA). Cholesterol and N-methyl-2-pyrrolidone (NMP) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dimethylsulfoxide (DMSO) was obtained from Amresco (Ohio, USA). All other solvents were of HPLC grade and triple distilled water was used.
Preparation of EA-loaded niosomes
The vesicles were prepared by reverse phase evaporation (REV) method [21] ether was slowly removed under reduced pressure using a rotary evaporator (60 rpm) until niosomal suspension was completely formed. The dispersion was evaporated about 15 min and then nitrogen gas was purged into dispersion for substitution of diethyl ether. In order to obtain niosomes with homogeneous size, REV vesicles were sonicated for 15 min and submitted to extrusion process for 3 times by an extruder device (Lipexä, Northern Lipids, BC, Canada), equipped with a 400 nm pore size polyester membrane (Cyclopore Ò , Whatman, NJ, USA). The maximum pressure was set at 800 psi as well as the temperature was controlled at 45 C during the extrusion process.
Characterization of niosomes
Niosomes were characterized by optical microscopy and transmission electron microscopy (TEM) for vesicle formation and morphology. Optical micrographs were obtained with a Nikon TE-2000 inverted light microscope (magnification 900Â). For TEM, a drop of vesicle dispersion was applied to a 200 mesh formvar copper grid and was stained with a 1% phosphotungstic acid. Then samples were observed under a transmission electron microscope (Hitachi Model H-7000, Tokyo, Japan).
Size and size distribution of niosomes were determined by photon correlation spectroscopy (PCS) with a Malvern
Zetasizer ZS (Malvern Instruments, UK). The mean particle size (z-ave) and polydispersity index (PI) values were obtained by averaging of 10 measurements at an angle of 90 in 10 mm diameter cells at 25 C. The real refractive index and the imaginary refractive index were set at 1.456 and 0.01, respectively.
Determination of entrapment efficiency
The percentage of EA-loaded niosomes (% E.E.) was determined by ultrafiltration using centrifugal filter tubes with a molecular weight cut-off of 30 kDa which were centrifuged (Optimaä Model LE-80K, Beckman, USA) at 10,000 rpm for 15 min. Niosomal pellets were dissolved in methanol and then diluted 10 folds with methanol and 0.1% v/v phosphoric acid in water (1:1 v/v). The concentrations of EA in EA-loaded niosomes and ultrafiltrate (free drug) were analyzed using HPLC method. Each formulation was performed in duplicates and each replicate sample was diluted and analyzed for three times. The percentage of EA entrapment efficiency was calculated using the following equation:
Total amount of added EA Â 100
HPLC analysis
EA concentrations were measured by HPLC (Agilent 1200 series, Waldbronn, Germany). The stationary phase was Hypersil Ò ODS C18 reversed-phase column (250 mm Â 4.6 mm Â 5 mm) used in isocratic mode at ambient temperature. The mobile phase was a mixture of 0.1% phosphoric acid, methanol and acetronitrile (42:48:10, v/v). The UV detection was performed at a wavelength of 254 nm, the flow rate was 0.8 ml/min and the injection volume was 20 ml. Prior to the analysis, the HPLC validation parameters including precision, accuracy and linearity were determined according to USP guideline [22] . Linearity was observed in concentration range of 0.05e10 mg/ml with a correlation coefficient value of 0.9999. The valves of coefficients of variation for intraday and interday were less than 2% and the percent recovery was 100.15%.
Stability of EA-loaded niosomes
The niosomal dispersions were stored at 4, 25 and 40 C. The % remaining of EA in the niosomes was evaluated by HPLC spectrophotometry over 4-month periods.
2.7.
Skin permeation study
Skin preparation
Human skin samples were obtained by abdominoplasty surgeries from female patient ranging in age from 25 to 60 years supported by Yanhee Hospital, Bangkok, Thailand. The study was carried out with the approval of the Committee on Human Rights Related to Human Experimentation, Mahidol University, Bangkok, Thailand. The excess adipose layer was sectioned off from the received tissues by dissecting with the surgical scissors. Then, the skin composed of epidermis and underlying dermis was further used for in vitro skin distribution study. For in vitro permeation study, the epidermis was separated from the dermis using the heat separation technique. The skin was immersed into hot water controlled temperature at 60 C for 1 min. Then, the epidermal layer was carefully separated from the dermis using blunt forceps to produce intact sheets ready for mounting on diffusion cells. The obtained epidermis was wrapped with aluminium foil and stored at À20 C until used. The stored epidermis was allowed to thaw, cut into 4.5 Â 4.5 cm 2 pieces and hydrated by placing in isotonic phosphate buffer in a refrigerator (at about 4 C) overnight before used.
In vitro permeation study
In vitro permeation studies through human epidermis were investigated using Franz diffusion cells. The diffusion cells were thermo-regulated with a water jacket at 37 C. The epidermis was excised from human skins and mounted on Franz diffusion cells. A mixture of isotonic phosphate buffer pH 5.5 and isopropyl alcohol at the ratios of 90 and 10 (%, v/v) was used as an acceptor medium to provide the sink condition during the experiment and because of an appropriate solubility of EA in isopropyl alcohol. After 24 h, the amounts of EA in acceptor fluids and in the epidermis were analyzed by HPLC spectroscopy.
To determine EA in the epidermis, the epidermis was removed and rinsed with water and isopropanol and subsequently dried with a cotton swab. This procedure was done in triplicate. Briefly, the skins were cut into small pieces and soaked in 1 ml of methanol for 12 h in a closed tube. Subsequently, it was subjected to an ultrasonic for three cycles of 15 min to avoid the raise in the temperature during extraction process. To ensure sufficient extraction of EA from skin, the residual extracted skin was performed in the same manner as mentioned above. It was found that no HPLC peak signal of EA was detected (LOD ¼ 10 ng/ml) indicating a complete extraction at the first extraction.
Skin distribution study
To investigate the distribution of EA from niosomal formulations after being applied on the human skin, confocal laser scanning microscopy (CLSM) was performed. Fortunately, EA molecule can be detected by fluorescence detector. Therefore, EA distribution in the different skin layers was investigated using CLSM (FluoView FV1000 with IX2 inverted microscope: Multi-line Argon laser exciting wavelengths of 457 and 488 nm, and HeliumeNeon green laser exciting wavelength of 543 nm). The emission wavelengths were set at 488 and 547 nm. The images were recorded by setting the camera integration time to 10 ms. Sample speed was 4.0 mm/pixel. The objective lens was in the magnification of 20Â (Olympus, microscope, Japan). In this study, the mixture of phosphate buffer pH 5.5 and isopropyl alcohol at the ratio of 90 and 10 (%, v/v) was used as an acceptor medium. After applying EA-loaded niosomes and EA solution on the skin surface, at 24 h, the skin was rinsed with distilled water. Then, the treated skins were removed from the Franz diffusion cells. The skin was sectioned into the pieces of 1 cm 2 size and evaluated for depth of EA penetration.
The full skin thickness (epidermis and underlying dermis) was optically scanned at different increments through the z-axis of a CLS microscope. The skin slices were investigated under both normal light and fluorescence microscopes. The images from the two techniques were overlaid to obtain the information of the EA distribution in the different skin layers.
Statistical analysis
Statistical analysis of difference in the physicochemical properties among predetermined intervals in the some formulation and between formulations was performed by using paired-t test and one-way analysis of variance (one-way ANOVA), respectively. The level of significance was taken at p value of 0.05.
3.
Results and discussion
Morphology, vesicle size and % entrapment efficiency
Vesicle formation in the presence of the enhancers was confirmed by optical microscopy and TEM. Fig. 1 (A1, A2) shows the obtained niosomes were spherical shape and multilamellar vesicles under optical microscope which the mean vesicle sizes in submicron range. In addition, the similar results were displayed by TEM images as shown in Fig. 1 (A2,  B2) . In general, an addition of chemical penetration enhancers (10% v/v DMSO or 1% v/v NMP) into the niosomal formulations did not alter vesicle formation. The vesicles could normally 
form with the presence of enhancers, and homogeneous white dispersion of niosomes without large dispersed particles or curd was obtained.
The vesicle sizes of all EA-free niosomes were in the range of 396e511 nm, as seen in Table 1 . After EA was entrapped into the niosomes, the vesicle size of the niosomes significantly increased ( p > 0.05). In addition, after submitted to extrusion process, the niosomes of small and homogeneous size were obtained with the mean vesicle size of 312e402 nm and PI values lower than 0.4 (Table 1) . Interestingly, after extrusion the vesicle sizes of the DMSO niosomes were larger than the NMP niosomes which may be due to the fact that NMP could have more effect on increasing fluidity of vesicular membrane resulting in ease of size reduction when subjected to extrusion process. The change of niosomes size is an important parameter which can influence both vesicular properties such as entrapment efficiency and stability, as well as skin-vesicle interactions.
The % E.E. of all niosomes was in between 25.63% and 38.73% (Table 1 ). In particular, the addition of DMSO and NMP increased % E.E of the niosomes. This may be resulted from the high solubility of EA in the enhancers (6.15 mg/ml in DMSO and 55.42 mg/ml in NMP). The DMSO niosomes had the lower entrapment efficiency than the NMP niosomes which may be described as the lower solubility of EA in DMSO. The higher % E.E. of NMP niosomes could be explained from the high solubility of EA in both PEG and NMP, and PEG molecules can localize between double vesicular layers which may also carry associated NMP with them. In addition, it was reported that NMP acts as penetration enhancer by fluidizing lipid domain (alkyl chains) of the stratum corneum [23, 24] . The presence of NMP in the niosome bilayer could produce the same effect, fluidizing lipid domain of vesicle membrane, leading to an increased space in the bilayer for the EA incorporation.
Stability of EA-loaded niosomes
The results of the stability study of EA entrapped in various niosomes stored at 4, 25 and 40 C for 4 months are shown in Fig. 2 . At 4 C, the EA in all niosomes exhibited a good stability, which the percentages of EA remaining were almost 100. At higher temperature (25 C), the percentages of EA remaining decreased to 40%e60%. Likewise, at 40 C, they dramatically decreased to below 30%. A direct relationship between a decrease in % E.E. and the storage time as increasing the temperature indicated the high degree of leaching. The higher EA leakage at higher temperature may be due to the higher fluidity of lipid bilayers at high temperature [25] . It is well known that the gel to liquid phase transition temperature of the vesicular bilayers played an important role in niosome formation and stability which was influenced by types of non-ionic surfactants, mole ratio of surfactant and cholesterol [1] . The stability of niosomes would be improved by increasing the phase transition temperature of the system by changing surfactant type and the surfactant/lipid level.
3.3.
In vitro permeation of EA-loaded niosomes Fig. 3 shows the amount of EA in the epidermis and the acceptor medium after applying EA-loaded niosomes or EA solution for 24 h. The amount of EA in epidermis after applying all niosomes was much higher than the EA solution.
In addition, the DMSO niosomes gave significantly higher amount of EA in epidermis than the NMP niosomes. Conversely, the NMP niosomes gave significantly higher amount of EA in acceptor medium than the DMSO niosomes. This indicated that the NMP niosomes could penetrate through epidermis into dermis higher than the DMSO niosomes which may be resulted from the higher penetration enhancement efficiency of NMP [26] which could promote 
lipid fluidity by disruption of the ordered structure of the lipid chains [27] . Therefore, the DMSO niosomes gave an advantage on the delivery to the epidermis layer, while the NMP niosomes were better for delivering EA to the dermis layer.
Skin distribution of EA-loaded niosomes
CLSM studies were conducted to evaluate the extent of penetration and transdermal potential of the permeated system as depicted an increase in both the depth of penetration and in fluorescence intensity. The CLSM images were obtained from overlaying the bright field images and fluorescence images of the same area. Each image was one of the zstack at 15 mm depth. Fig. 4 shows the fluorescence images of the epidermis and dermis layers of human skin after being treated with the EA-loaded niosomes. The CLSM images of the DMSO niosomes (Fig. 4A) showed effectiveness in permeating EA up to 120 mm which showed high fluorescence intensity at the penetration depth between 30e90 mm (epidermis layer depth) and lower fluorescence intensity at the depth up to 120 mm (underlying dermis depth). Thus, the DMSO niosomes had high ability to deliver EA to the viable epidermis layer which small amount of EA penetrated into dermis layer. Meanwhile, the penetration of the NMP niosomes to dermis layer was better than the DMSO niosomes as revealed by the higher fluorescence intensity of EA at the deeper skin layer (90e120 mm depth), as shown in Fig. 4B . According to the obtained results, it confirmed that the skin enhancers affected the permeation of EA to the epidermis or dermis in accordance with the results from in vitro permeation study.
Conclusion
The niosomes of 2:1 Span 60 and Tween 60 using PEG as the solubilizer could be formed in the presence of chemical enhancers (DMSO and NMP). The vesicle shape was spherical multilamellar vesicles as assessed by optical microscopy and TEM. The mean particle sizes were in range of 312e402 nm and PI values were lower than 0.4. An addition of enhancers increased the entrapment efficiency of the EA-loaded niosomes. The results of the skin distribution of EA-loaded Fig. 4 e CLSM images revealing the penetration and distribution of EA within the human skin after treated with (A) the DMSO niosomes and (B) the NMP niosomes for 24 h.
niosomes by CLSM were in agreement with the results of in vitro permeation which showed that the DMSO niosomes had the higher fluorescence intensity in the epidermis layer whereas the NMP niosomes had the higher fluorescence intensity in the dermis layer. Therefore, the chemical enhancers influenced the permeation of EA from the EA-loaded niosomes through the human skin.
